TherapeuticsMD (TXMD) Total Debt (QoQ) (2012 - 2022)
TherapeuticsMD (TXMD) Total Debt (QoQ) (2012 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 3.11% |
| Jun 30, 2022 | -55.25% |
| Mar 31, 2022 | 7.75% |
| Dec 31, 2021 | 0.82% |
| Sep 30, 2021 | 0.80% |
| Jun 30, 2021 | -1.96% |
| Mar 31, 2021 | -20.50% |
| Dec 31, 2020 | 0.27% |
| Sep 30, 2020 | -2.77% |
| Jun 30, 2020 | 0.15% |
| Mar 31, 2020 | 25.07% |
| Dec 31, 2019 | 0.14% |
| Sep 30, 2019 | 0.14% |
| Jun 30, 2019 | 164.07% |
| Mar 31, 2019 | 0.16% |
| Dec 31, 2018 | 0.16% |
| Sep 30, 2018 | 0.16% |
| Mar 31, 2013 | -97.21% |
| Dec 31, 2012 | 15.70% |
| Sep 30, 2012 | 0.25% |